Black Hawk Acquisition - Class A Share Price Today
Black Hawk Acquisition - Class A opened at $5.20, in line with its previous close of $5.20. In the last trading session, the stock traded between $5.11 and $5.38. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 3 years ago in Black Hawk Acquisition - Class A is now worth
$ 49.96
Resulting in a loss of
$ 50.04 (50.04%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
No analyst rating data available.
Markets Today
Today's Change
$-0.14 (-2.67%)
Day High
$5.38
Day Low
$5.11
Day Open
$5.20
Prev Close
$5.20
Volume
1,557
1W Return
-7.90%
1M Return
-59.51%
3M Return
-57.42%
6M Return
-56.78%
1Y Return
-54.81%
Fundamentals
Market Cap ($ Mn)
21
PE Ratio
107.70
PB Ratio
2.43
PEG Ratio
-
ROE
2.65%
ROCE
-1.74%
EPS (TTM)
-
Investment Returns
1 Week
-7.90%
1 Month
-59.51%
3 Months
-57.42%
6 Months
-56.78%
9 Months
-55.84%
Financials
Quarterly
All values in $ Mn
0.0
May 25
0.0
Aug 25
0.0
Nov 25
0.0
Feb 26
0.0
May 26
0.0
Aug 26
Updates
14Oct
Black Hawk Acquisition shareholders approve Vesicor Therapeutics merger
Shareholders approved the business combination with Vesicor Therapeutics. Quorum achieved with 77.3% of outstanding shares voting. Meeting held on October 13, 2026 with record date September 1, 2026. Approval covers the Business Combination Agreement dated April 26, 2025.
1mo ago
25Sep
Black Hawk, Vesicor enter forward purchase agreement with Meteora for 1.35M shares
Black Hawk Acquisition Corp and Vesicor Therapeutics signed a forward purchase agreement with Meteora on September 22, 2026. The agreement covers up to 1,350,000 shares, comprising recycled and additional shares. Black Hawk will domesticate as a Delaware corporation and rename to Vesicor Therapeutics Holdings, Inc. The initial reset price for the forward transaction is set at $10.00 per share. Prepayment amounts from the trust account are reduced by the cost of any additional shares purchased by Meteora.
